After SMg treatment, 50 to 60% of the CD45+ cells were located within the inner part of the tumor (0-50% of tumor radius) with 10% of cells present within the tumor core at D15 (Fig. 4D, E). This evidence concerns the gene PTPRC and neoplasm.